Sputnik V Vaccine Clinical Trial India
- All
- News
-
"Trial Data Clear, Transparent...": Russian Scientists Defend Sputnik V
Russian scientists leading clinical studies for the Sputnik V COVID-19 vaccine have responded to claims of "serious concerns over interim results from phase 3 trials" by stressing their data meets "clear and transparent standards..."
-
17 Volunteers Given Sputnik V Vaccine During Clinical Trial In Pune
A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said today.
-
Dr Reddy's, Russian Firm RDIF Begin Clinical Trials For Covid Vaccine Sputnik V In India
Dr Reddy's Laboratories and the Russian Direct Investment Fund (RDIF) on Tuesday announced the start of adaptive phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving necessary clearance from the Central Drugs Laboratory in Himachal Pradesh.
-
Dr. Reddy's And RDIF Commence Clinical Trials For Sputnik V Vaccine In India
The clinical trials are being conducted by JSS Medical Research as the clinical research partner
-
Bengal Likely To Lose Chance To Conduct Sputnik V Vaccine Phase II Trial
West Bengal will lose the chance to conduct Phase II clinical trial of Russian COVID-19 vaccine candidate Sputnik V because of the delay in grant of approval by the state government, a top official of an organisation involved in facilitating the exercise said on Sunday.
-
Russia Covid Vaccine May Reach Kanpur Next Week For Phase-2 Trial: Report
The first batch of Russia's Sputnik V vaccine for COVID-19 is likely to reach Kanpur's Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine's Phase 2 and Phase 3 human clinical trials will be conducted.
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
Dr Reddy's Seeks Nod For Phase 3 Trial Of Russian Covid Vaccine In India
Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct phase-3 human clinical trials of the Russian vaccine Sputnik V against COVID-19 in India, sources said.
-
Clinical Trial Of COVID-19 Vaccine, Sputnik V, To Begin In India This Month: Russia
The clinical trials of Sputnik V vaccine for coronavirus will be held this month in several countries including India, confirmed Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) on Monday.
-
"Trial Data Clear, Transparent...": Russian Scientists Defend Sputnik V
Russian scientists leading clinical studies for the Sputnik V COVID-19 vaccine have responded to claims of "serious concerns over interim results from phase 3 trials" by stressing their data meets "clear and transparent standards..."
-
17 Volunteers Given Sputnik V Vaccine During Clinical Trial In Pune
A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said today.
-
Dr Reddy's, Russian Firm RDIF Begin Clinical Trials For Covid Vaccine Sputnik V In India
Dr Reddy's Laboratories and the Russian Direct Investment Fund (RDIF) on Tuesday announced the start of adaptive phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving necessary clearance from the Central Drugs Laboratory in Himachal Pradesh.
-
Dr. Reddy's And RDIF Commence Clinical Trials For Sputnik V Vaccine In India
The clinical trials are being conducted by JSS Medical Research as the clinical research partner
-
Bengal Likely To Lose Chance To Conduct Sputnik V Vaccine Phase II Trial
West Bengal will lose the chance to conduct Phase II clinical trial of Russian COVID-19 vaccine candidate Sputnik V because of the delay in grant of approval by the state government, a top official of an organisation involved in facilitating the exercise said on Sunday.
-
Russia Covid Vaccine May Reach Kanpur Next Week For Phase-2 Trial: Report
The first batch of Russia's Sputnik V vaccine for COVID-19 is likely to reach Kanpur's Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine's Phase 2 and Phase 3 human clinical trials will be conducted.
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
Dr Reddy's Seeks Nod For Phase 3 Trial Of Russian Covid Vaccine In India
Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct phase-3 human clinical trials of the Russian vaccine Sputnik V against COVID-19 in India, sources said.
-
Clinical Trial Of COVID-19 Vaccine, Sputnik V, To Begin In India This Month: Russia
The clinical trials of Sputnik V vaccine for coronavirus will be held this month in several countries including India, confirmed Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) on Monday.
